Publication: [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
cris.virtualsource.author-orcid | b45b7422-97de-484f-9a83-b0bf5fbacd4b | |
datacite.rights | metadata.only | |
dc.contributor.author | Funke, Manuela | |
dc.contributor.author | Geiser, Thomas | |
dc.date.accessioned | 2024-12-13T15:39:43Z | |
dc.date.available | 2024-12-13T15:39:43Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment. | |
dc.description.numberOfPages | 5 | |
dc.description.sponsorship | Universitätsklinik für Pneumologie | |
dc.identifier.pmid | 26884217 | |
dc.identifier.publisherDOI | 10.1024/0040-5930/a000751 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/192848 | |
dc.language.iso | de | |
dc.publisher | Huber | |
dc.relation.ispartof | Therapeutische Umschau | |
dc.relation.issn | 0040-5930 | |
dc.relation.organization | DCD5A442BB14E17DE0405C82790C4DE2 | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.title | [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]. | |
dc.type | article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 29 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 25 | |
oaire.citation.volume | 73 | |
oairecerif.author.affiliation | Universitätsklinik für Pneumologie | |
oairecerif.author.affiliation | Universitätsklinik für Pneumologie | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 93081 | |
unibe.journal.abbrevTitle | Ther Umsch | |
unibe.refereed | true | |
unibe.subtype.article | contribution |